Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation.

Kubacka, Marta; Zietz, Annaelle; Schaedelin, Sabine; Polymeris, Alexandros A; Hert, Lisa; Lieb, Johanna; Wagner, Benjamin; Seiffge, David; Traenka, Christopher; Altersberger, Valerian L; Dittrich, Tolga; Fladt, Joachim; Fisch, Urs; Thilemann, Sebastian; De Marchis, Gian Marco; Gensicke, Henrik; Bonati, Leo H; Lyrer, Philippe; Engelter, Stefan T and Peters, Nils (2022). Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation. (In Press). Cerebrovascular diseases, pp. 1-8. Karger 10.1159/000527739

[img]
Preview
Text
document.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (366kB) | Preview

INTRODUCTION

Measures of cerebral small vessel disease (cSVD), such as white matter hyperintensities (WMH) and cerebral microbleeds (CMB), are associated with an unfavorable clinical course in stroke patients on oral anticoagulation (OAC) for atrial fibrillation (AF). Here, we investigated whether similar findings can be observed for global cortical atrophy (GCA).

METHODS

Registry-based prospective observational study of 320 patients treated with OAC following AF stroke. Patients underwent magnetic resonance imaging (MRI) allowing assessment of GCA. Using the simplified visual Pasquier scale, the severity of GCA was categorized as follows: 0: no atrophy, 1: mild atrophy; 2: moderate atrophy, and 3: severe atrophy. Using adjusted logistic and Cox regression analysis, we investigated the association of GCA using a composite outcome measure, comprising: (i) recurrent acute ischemic stroke (IS); (ii) intracranial hemorrhage (ICH); and (iii) death.

RESULTS

In our time to event analysis after adjusting for potential confounders (i.e., WMH, CMB, age, sex, diabetes, arterial hypertension, coronary heart disease, hyperlipidemia, and antiplatelet use), GCA was associated with an increased risk for the composite outcome in all three degrees of atrophy (grade 1: aHR 3.95, 95% CI 1.34-11.63, p = 0.013; grade 2: aHR 3.89, 95% CI 1.23-12.30, p = 0.021; grade 3: aHR 4.16, 95% CI 1.17-14.84, p = 0.028).

CONCLUSION

GCA was associated with our composite outcome also after adjusting for other cSVD markers (i.e., CMB, WMH) and age, indicating that GCA may potentially serve as a prognostic marker for stroke patients with atrial fibrillation on oral anticoagulation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Seiffge, David Julian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1015-9770

Publisher:

Karger

Language:

English

Submitter:

Pubmed Import

Date Deposited:

19 Dec 2022 12:54

Last Modified:

19 Dec 2022 18:39

Publisher DOI:

10.1159/000527739

PubMed ID:

36513036

Uncontrolled Keywords:

Atrial fibrillation Global cortical atrophy Intracerebral hemorrhage Small vessel disease Stroke

BORIS DOI:

10.48350/175937

URI:

https://boris.unibe.ch/id/eprint/175937

Actions (login required)

Edit item Edit item
Provide Feedback